Clinical Features and Therapeutic Outcomes Comparing Primary Mediastinal Large B-cell Lymphoma to Mediastinal Hodgkin Disease.

Puerto Rico health sciences journal Pub Date : 2024-06-01
Rubén J Cruz-Chamorro, Joshua L Rodríguez-López, Michael J González-Soto, Raúl Arroyo-Suárez, Carmen Ortiz-Sánchez, Jarline Encarnación-Medina, Fernando Cabanillas
{"title":"Clinical Features and Therapeutic Outcomes Comparing Primary Mediastinal Large B-cell Lymphoma to Mediastinal Hodgkin Disease.","authors":"Rubén J Cruz-Chamorro, Joshua L Rodríguez-López, Michael J González-Soto, Raúl Arroyo-Suárez, Carmen Ortiz-Sánchez, Jarline Encarnación-Medina, Fernando Cabanillas","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Currently, there is limited data available comparing Primary Mediastinal Large B-cell Lymphoma (PMBL) and mediastinal Hodgkin disease, nodular sclerosis type (HDNS). This is a retrospective cohort study that compares the clinical features, histology through immunohistochemistry (IHC) and treatment outcomes of 19 cases of PMBL and 39 cases of HDNS diagnosed over 13 years at a single institution in San Juan, PR. Superior Vena Cava syndrome (SVCS) and elevated Lactate Dehydrogenase (LDH) levels were more frequently seen in the PMBL cohort. At the median follow-up visit, of 74 months, no significant difference was seen in overall survival or progression free survival between PMBL and HDNS. Almost all of the relapses in the PMBL group occurred within 12 months of diagnosis. Our data suggests that PMBL and HDNS differ in their clinical presentation and have a favorable prognosis.</p>","PeriodicalId":94183,"journal":{"name":"Puerto Rico health sciences journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Puerto Rico health sciences journal","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Currently, there is limited data available comparing Primary Mediastinal Large B-cell Lymphoma (PMBL) and mediastinal Hodgkin disease, nodular sclerosis type (HDNS). This is a retrospective cohort study that compares the clinical features, histology through immunohistochemistry (IHC) and treatment outcomes of 19 cases of PMBL and 39 cases of HDNS diagnosed over 13 years at a single institution in San Juan, PR. Superior Vena Cava syndrome (SVCS) and elevated Lactate Dehydrogenase (LDH) levels were more frequently seen in the PMBL cohort. At the median follow-up visit, of 74 months, no significant difference was seen in overall survival or progression free survival between PMBL and HDNS. Almost all of the relapses in the PMBL group occurred within 12 months of diagnosis. Our data suggests that PMBL and HDNS differ in their clinical presentation and have a favorable prognosis.

比较原发性纵隔大 B 细胞淋巴瘤和纵隔霍奇金病的临床特征和治疗效果。
目前,比较原发性纵隔大 B 细胞淋巴瘤(PMBL)和纵隔霍奇金病结节硬化型(HDNS)的数据非常有限。这是一项回顾性队列研究,通过免疫组化技术(IHC)比较了 13 年来在美国圣胡安市一家医疗机构确诊的 19 例原发性纵隔大 B 细胞淋巴瘤和 39 例纵隔霍奇金病结节硬化型(HDNS)的临床特征、组织学和治疗效果。上腔静脉综合征(SVCS)和乳酸脱氢酶(LDH)水平升高在 PMBL 患者中更为常见。在 74 个月的中位随访中,PMBL 和 HDNS 的总生存期和无进展生存期没有明显差异。PMBL 组的复发几乎都发生在确诊后的 12 个月内。我们的数据表明,PMBL 和 HDNS 的临床表现不同,预后良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信